Tohoku Fukushi University · Faculty of Health Sciences · 教授

Research keywordsfollicular lymphoma・acute myeloid leukemia・natural killer cell leukemia・hematologic oncology・immune checkpoint inhibitors・obinutuzumab

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Obinutuzumab maintenance versus observation for patients with newly diagnosed high tumor burden follicular lymphoma who achieved complete metabolic response after obinutuzumab plus bendamustine induction therapy: a multicenter, randomized, phase III study (JCOG2008, MAIN study).2025
• Prevalence of keratoconus and keratoconus suspect, and their characteristics on corneal tomography in a population-based study.2025
• Glasdegib with intensive/nonintensive chemotherapy in Japanese patients with untreated acute myeloid leukemia or high-risk myelodysplastic syndromes.2024
• Amino acid influx via LAT1 regulates iron demand and sensitivity to PPMX-T003 of aggressive natural killer cell leukemia2024

• Official profile